This comprehensive session focuses on simplifying type 2 diabetes management through practical insights on DPP-4 inhibitors, with a special emphasis on linagliptin and its role across the disease trajectory. The discussion covers patient selection, renal considerations, cardiovascular safety, long-term glycemic durability, and real-world positioning in diverse clinical scenarios. A clinically oriented update designed to support confident, individualized diabetes care in everyday practice.

Simplifying the Trajectory of T2DM in Current Era: DPP-4i Across the Treatment Landscape

This World Diabetes Day, join the Empower Symposium! A special educational event focused on advancing holistic and personalized diabetes care. Join leading experts as they share insights that combine science, empathy, and innovation to redefine patient outcomes in Type 2 Diabetes Mellitus.

Dr. Banshi Saboo, Chief Diabetologist & Chairman of Dia Care, Ahmedabad, will present the Holistic CRM Approach — a Diabetes India accredited module highlighting integrated patient management strategies. Dr. Sanjay Kalra, Consultant & Head Endocrinologist at Bharti Research Institute of Diabetes & Endocrinology, Karnal, will follow with Personalized Care in T2DM: State of the Art, exploring individualized treatment approaches with cardiovascular focus. The session concludes with a live panel discussion and audience Q&A.

*A certificate will be provided to the attendees who attend the Diabetes India accredited session on Holistic CRM Approach by Dr. Banshi Saboo.

World Diabetes Day

“My Most Memorable Case” is a clinical storytelling series where top doctors share the one case that truly challenged their thinking. These aren’t textbook examples - they’re the curveballs, the cases that forced them to question assumptions, think on their feet, and sometimes even break the mold. Each episode is filled with intrigue, diagnostic dilemmas, and brilliant clinical insight, all wrapped in captivating narratives that make learning fun. Join us for the premiere episode on 30th July, a must-attend for anyone who loves Medicine and a good story.

My Most Memorable Case #1 - The foot that launched a thousand tests

Metformin is one of the most commonly prescribed medications for the treatment of type 2 diabetes. It's been around for nearly five decades. But what makes it so popular? How long will it be popular? Is it at risk of being replaced? This agent's pharmacological properties are now being lauded for use in a variety of other indications. New aspects of its personality are emerging, piqueing the scientific community's interest in this 'middle-aged molecule'. Join us live with Dr. Sanjay Kalra to learn more about this molecule, also known as the 'Midlife maturity, maiden charm' diabetes drug.

Metformin - Should we stop prescribing it in type 2 DM?

Consultant and Head Endocrinologist, Bharti Research Institute of Diabetes & Endocrinology, Karnal, Haryana

Dr. Sanjay Kalra

5

5.5k

109.1k

4.7

Sessions Taken

855

4.8

1.6k

4.8

1.3k

4.6

2.8k

4.8